14/12/2004
ReGen Therapeutics Plc (‘ReGen’ or ‘the Company’) announces that it has today placed with new and existing shareholders 54.26 million new ordinary shares (‘New Shares’) at 2.3p per share to raise £1.25m before expenses (‘Placing’).
Application has been made for the New Shares to be admitted to the Alternative Investment Market of the London Stock Exchange Plc and dealings are expected to commence at 8am on 15th December 2004
Executive Chairman Percy Lomax commented that ‘The cash will be used to explore further opportunities’.
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No: 020 7960 6007